North America Hemoglobin A1c Testing Devices Market Growth Forecast 2031: Size, Share, and Industry Trends
North America continues to dominate the Hemoglobin A1c Testing Devices Market due to the high prevalence of diabetes, advanced healthcare infrastructure, and widespread adoption of diagnostic technologies. The region benefits from strong reimbursement frameworks, increasing awareness regarding diabetes management, and continuous investments in point-of-care testing solutions. Growing demand for early diagnosis and routine monitoring of blood glucose levels is further supporting market expansion across North America.
Market Overview
According to The Insight Partners, the Hemoglobin A1c Testing Devices Market is expected to reach US$ 3.7 billion by 2031 and is anticipated to register a CAGR of 7.0% during 2025–2031. The market is experiencing substantial growth owing to the increasing global burden of diabetes, rising awareness regarding disease management, and growing demand for accurate and rapid diagnostic solutions.
Hemoglobin A1c (HbA1c) testing plays a crucial role in monitoring long-term blood glucose levels and assessing diabetes management effectiveness. Unlike conventional glucose tests that provide…